SIRS)： a prospective study. JAMA，1995，11：117-123.
2 Balk RA.Pathogenesis and management of multiple organ dysfunction or failure in severe sepsis and septic shock. Crit Care Clin，2000，16：337-352.
3 Cheadle WG.The human leukocyte antigens and their relationship to infection. Am J Surg，1993，165：75-81.
4 Blackwell TS，JW Christman. Sepsis and cytokines： current status. Br J Anaesth，1996，77：110-117.
5 Sibbald WJ，JL Vincent. Round table conference on clinical trials for the treatment of sepsis. Crit Care Med，1995，23：394-399.
6 Sachse C，M Prigge， G Cramer，et al. Association between reduced human leukocyte antigen (HLA)-DR expression on blood monocytes and increased plasma level of interleukin-10 in patients with severe burns. Clin Chem Lab Med，1999，37：193-198.
7 Bone RC， Balk RA， Cerra FB， et al. American College of Chest Physicians/society of critical care medicine consensus conference： definition for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med，1992，20(6)：864-874.
8 Casey LC，Balk R A，Bone RC.Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med，1993，119：771-778.
9 Fumeaux T，J Pugin. Role of interleukin-10 in the intracellular sequestration of human leukocyte antigen-DR in monocytes during septic shock. Am J Respir. Crit Care Med，2002，166：1475-1482.
上一页 [1] [2] [3]